Stay updated with breaking news from Jonathanp Piccini. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
It's actually two leadless pacemakers, one atrial and the other ventricular, linked as if in a wireless network, that together maintained true AV synchronous pacing in a short-term study.
/PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative...
/PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative...
The procedure's success seemed to depend on dosage, patient age, and type of cardiac surgery in this small phase-2 study with a sham-control group.
Sicker patients in the EAST-AFNET4 trial showed a pronounced survival advantage from early rhythm control, compared with a rate-control-first approach, while those with fewer comorbidities missed out.